Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: Parents' and children's perspectives

Journal of Child Neurology

Volumn 23, Issue 9, 2008, Pages 1036-1042

  Berger, Itai ^a   Dor, Talia ^a   Nevo, Yoram ^a   Goldzweig, Gil ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Attention deficit hyperactivity disorder; Attitudes; Methyl phenidate; Neurologist

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CONSULTATION; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTAL ATTITUDE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT INFORMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; BIAS (EPIDEMIOLOGY); CAREGIVERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HEALTH EDUCATION; HUMANS; MALE; METHYLPHENIDATE; PARENTS; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; TIME;

EID: 50449109018     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808317726     Document Type: Article

References (21)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Washington, DC: American Psychiatric Association; 1994.
2. Spencer TJ, Biederman J., Wilens TE, Faraone SV Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002; 63 (suppl 12): 3S-9S.
3. Subcommittee on attention-deficit/hyperactivity disorder and committee on quality improvement. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001; 108: 1033-1044.
4. Zuvekas SH, Vitiello B., Norquist GS Recent trends in stimulant medication use among US children. Am J Psychiatry. 2006; 163: 579-585.
5. Parker-Pope T. Ritalin use not without risks. Wall Street Journal Star Tribune. February 6, 2005: E3 (col 1 - 4).
6. Schonwald A., Lechner E. Attention deficit/hyperactivity disorder: complexities and controversies. Curr Opin Pediatr. 2006; 18: 189-195.
7. Rowland R. Ritalin debate: Are we over medicating? CNN.com Web site. http://archives.cnn.com/2001/HEALTH/parenting/08/29/ritalin.schools/. Accessed August 29, 2001.
8. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006; 113: 203-212.
9. Kenna LA, Labbe L., Barrett JS, Pfister M. Modeling and simulation of adherence: Approaches and applications in therapeutics. AAPS J. 2005; 7: E390-E407.
10. Thiruchelvam D., Charach A., Schachar RJ Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001; 40: 922-928.
11. Lesesne C., Abramowitz A., Perou R., Brann E. Attention Deficit/ Hyperactivity Disorder: A Public Health Research Agenda. Atlanta, GA: US Department of Health and Human Services CDC; 2000.
12. Prince RL, Devine A., Dhaliwal SS, Dick IM Effects of calcium supplementation on clinical fracture and bone structure: Results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006; 166: 869-875.
13. Weiss MD, Gadow K., Wasdell MB Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006; 67 (suppl 8): 38-45.
14. Gau SS, Shen HY, Chou MC, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006; 16: 286-297.
15. Sanchez RJ, Crimson ML, Barner JC, Bettinger T., Wilson JP Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy. 2005; 25: 909-917.
16. Pelham WE, Gnagy EM, Burrows-Maclean L., et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001; 107: E105.
17. Kent MA, Camfield CS, Camfield PR Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med. 1999; 153: 1292-1296.
18. Pliszka SR Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action. Neuropsychol Rev. 2007; 17: 61-72.
19. Wolraich ML Attention-deficit hyperactivity disorder. Semin Pediatr Neurol. 2006; 13: 279-285.
20. Brown RT, Amler RW, Freeman WS, et al. Treatment of attention-deficit/ hyperactivity disorder: Overview of the evidence. Pediatrics. 2005; 115: e749-e757.
21. The MTA cooperative group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999; 56: 1073-1086.